Production (Stage)
BIOQUAL, Inc.
BIOQ
$43.19
-$0.25-0.58%
OTC PK
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -3.20% | -9.33% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -3.20% | -9.33% |
| Cost of Revenue | -- | -- | -- | 0.32% | 0.80% |
| Gross Profit | -- | -- | -- | -14.83% | -38.40% |
| SG&A Expenses | -- | -- | -- | 7.06% | 8.88% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | -- | 1.55% | 2.23% |
| Operating Income | -- | -- | -- | -76.89% | -114.03% |
| Income Before Tax | -- | -- | -- | -68.67% | -110.90% |
| Income Tax Expenses | -- | -- | -- | -47.89% | -120.53% |
| Earnings from Continuing Operations | -- | -- | -- | -72.06% | -108.44% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | -- | -72.06% | -108.44% |
| EBIT | -- | -- | -- | -76.89% | -114.03% |
| EBITDA | -- | -- | -- | -42.64% | -81.78% |
| EPS Basic | -- | -- | -- | -72.06% | -108.44% |
| Normalized Basic EPS | -- | -- | -- | -68.67% | -110.90% |
| EPS Diluted | -- | -- | -- | -72.24% | -108.55% |
| Normalized Diluted EPS | -- | -- | -- | -68.67% | -110.90% |
| Average Basic Shares Outstanding | -- | -- | -- | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | -- | -- | -- | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -50.00% | -50.00% |
| Payout Ratio | -- | -- | -- | 0.79% | -6.92% |